The use of anti-CD20 chimeric monoclonal antibody, rituximab in adult patients with treatment refractory immune thrombocytopenia

被引：0
|
作者：
Jacoub, J
Mchlayeh, W
Tabbara, I
Dave, HP
Siegel, R
Schechter, GP
机构：
[1] George Washington Univ, Washington, DC USA
[2] Vet Affairs Med Ctr, Washington, DC USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3950
引用
收藏
页码：74B / 74B
页数：1
相关论文
共 50 条
  • [41] Retreatment of 11 patients with immune thrombocytopenic purpura with the anti-CD20 monoclonal antibody, rituximab.
    Cooper, N
    Stasi, R
    Michel, M
    Bussel, JB
    BLOOD, 2003, 102 (11) : 86B - 86B
  • [42] Treatment of refractory chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody
    Guidi, S
    Bartolozzi, B
    Nozzoli, C
    Guglielmelli, P
    Lombardini, L
    Saccardi, R
    Vannucchi, AM
    Bosi, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S92 - S93
  • [43] Successful use of an anti-CD20 antibody (rituximab) for the treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease
    Helwig, A
    Freiberg-Richter, J
    Ehninger, G
    Bornhäuser, M
    Haack, A
    Hölig, K
    BONE MARROW TRANSPLANTATION, 2001, 27 : S223 - S223
  • [44] Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: A multicenter phase II study
    Coiffier, B
    Haioun, C
    Ketterer, N
    Engert, A
    Tilly, H
    Ma, D
    Johnson, P
    Lister, A
    Feuring-Buske, M
    Radford, JA
    Capdeville, R
    Diehl, V
    Reyes, F
    BLOOD, 1998, 92 (06) : 1927 - 1932
  • [45] Refractory autoimmune cytopenias, either associated with lymphoproliferative diseases or idiopathic in adult patients, treated with anti-CD20 monoclonal antibody (Rituximab).
    Garay, G
    Riveros, D
    Milone, J
    Fernandez, J
    Duarte, P
    Cacchione, R
    Dupont, J
    BLOOD, 2004, 104 (11) : 238B - 238B
  • [46] Anti-CD20 monoclonal antibody therapy in refractory immune thrombocytopenic purpura.
    Delgado, J
    Bustos, JG
    Jimenez-Yuste, V
    Garcia, B
    de Paz, R
    Gracia, J
    Villar, A
    Quintana, M
    Hernandez-Navarro, F
    BLOOD, 2001, 98 (11) : 59B - 59B
  • [47] Idiopathic membranous nephropathy (IMN) treatment with anti-CD20 monoclonal antibody Rituximab
    Lionaki, Sofia
    Sfikakis, Petros
    Theodoropoulou, Eleni
    Skalioti, Chrisanthi
    Iniotaki, Aliki
    Nakopoulou, Lydia
    Boletis, Ioannis
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 334 - 335
  • [48] Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia
    Hagberg, H
    Lundholm, L
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (03) : 609 - 611
  • [49] Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis
    Bhatia, A
    Ell, PJ
    Edwards, JCW
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (07) : 1099 - 1100
  • [50] Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance
    Mitchell R Smith
    Oncogene, 2003, 22 : 7359 - 7368
12345